Ala
n W
olf
fe,
1959
– 2
001
Co-funded by the EMBL Corporate Partnership Programme
www.embl.orgCop
yrig
ht ©
EM
BL
2019
ONLINE REGISTRATION ONLYwww.embl.de/training/events/2019/CHR19-01
Abstract Submission Deadline13 February 2019
Registration Deadline25 March 2019
Registration FeesAcademia 450 Euro
PhD Student 350 Euro
Industry 750 Euro
ContactEuropean Molecular Biology Laboratory
#EMBOChromatin
1 – 4 May 2019EMBL Advanced Training Centre Heidelberg I Germany
Chromatin and Epigenetics
ORGANISERS
Asifa Akhtar Max Planck Institute of Immunobiology and Epigenetics, Germany
Geneviève Almouzni Institut Curie, France
L. Stirling Churchman Harvard Medical School, USA
Ana Pombo Max Delbrück Center for Molecular Medicine, Germany
Chris Ponting The University of Edinburgh, UK
SPEAKERS
Asifa Akhtar Max Planck Institute of Immunobiology and Epigenetics, Germany
Geneviève Almouzni Institut Curie, France
Wendy Bickmore The University of Edinburgh, UK
Andrea Brand The Gurdon Institute, University of Cambridge, UK
Giacomo Cavalli IGH, University of Montpellier, France
Howard Y. Chang Stanford University, USA
L. Stirling Churchman Harvard Medical School, USA
Ibrahim Cissé Massachusetts Institute of Technology, USA
Xavier Darzacq University of California, Berkeley, USA
Caroline Dean John Innes Centre, UK
Joseph R. Ecker Salk Institute for Biological Studies, USA
Emma Farley University of California, San Diego, USA
Anne Ferguson-Smith University of Cambridge, UK
Polly Fordyce Stanford University, USA
Eileen Furlong EMBL Heidelberg, Germany
Edith Heard EMBL Heidelberg, Germany
Steven Henikoff Fred Hutchinson Cancer Research Center, USA
Gary Karpen University of California, Berkeley, USA
Jean-Christophe Marine VIB-KU Leuven Center for Cancer Biology, Belgium
Ana Pombo Max Delbrück Center for Molecular Medicine, Germany
Chris Ponting The University of Edinburgh, UK
Wolf Reik Babraham Institute, UK
Amos Tanay Weizmann Institute of Science, Israel
Igor Ulitsky Weizmann Institute of Science, Israel
Fred Winston Harvard Medical School, USA
